Improving Australia’s translational research outcomes with Andrew Maxwell

Australia ranks 25th in the world for innovation as per the Global Innovation Index, but only ranks 32nd for translation of research. 

In this episode of Med Tech Talks, Robert Klupacs speaks with experienced med tech entrepreneur and founder of Chatsworth Associates, Andrew Maxwell, about what Australia should do to improve the translation of our research. 

Andrew has a remarkable record in the international business arena, with a history of successful company launches and business growth in the biotech sector. 

In this episode, you will hear about: 

• Andrew's career pathway that lead him to founding Chatsworth Associates, a boutique advisory firm providing strategic advice to emerging and high growth companies in the biomedical and med tech industry.
• Hear from Robert and Andrew as they discuss the roles that governments, industry and superannuation funds can play in boosting the med tech ecosystem as well as the impact that large companies can have in growing our economy. 
• His thoughts on the med tech ecosystem and the path forward for Australian innovation.

Learn more about: 

• Andrew Maxwell and the team at Chatsworth Associates.
• Chatsworth Associates

Updated version 05/08/22